GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Smruthi Organics Ltd (BOM:540686) » Definitions » Equity-to-Asset

Smruthi Organics (BOM:540686) Equity-to-Asset : 0.59 (As of Mar. 2024)


View and export this data going back to 2005. Start your Free Trial

What is Smruthi Organics Equity-to-Asset?

Equity to Asset ratio is calculated as total stockholders equity divided by total asset. Smruthi Organics's Total Stockholders Equity for the quarter that ended in Mar. 2024 was ₹696 Mil. Smruthi Organics's Total Assets for the quarter that ended in Mar. 2024 was ₹1,182 Mil. Therefore, Smruthi Organics's Equity to Asset Ratio for the quarter that ended in Mar. 2024 was 0.59.

The historical rank and industry rank for Smruthi Organics's Equity-to-Asset or its related term are showing as below:

BOM:540686' s Equity-to-Asset Range Over the Past 10 Years
Min: 0.24   Med: 0.43   Max: 0.77
Current: 0.59

During the past 13 years, the highest Equity to Asset Ratio of Smruthi Organics was 0.77. The lowest was 0.24. And the median was 0.43.

BOM:540686's Equity-to-Asset is ranked better than
52.44% of 1087 companies
in the Drug Manufacturers industry
Industry Median: 0.58 vs BOM:540686: 0.59

Smruthi Organics Equity-to-Asset Historical Data

The historical data trend for Smruthi Organics's Equity-to-Asset can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Smruthi Organics Equity-to-Asset Chart

Smruthi Organics Annual Data
Trend Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24
Equity-to-Asset
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.48 0.66 0.77 0.65 0.59

Smruthi Organics Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Equity-to-Asset Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.65 - 0.66 - 0.59

Competitive Comparison of Smruthi Organics's Equity-to-Asset

For the Drug Manufacturers - Specialty & Generic subindustry, Smruthi Organics's Equity-to-Asset, along with its competitors' market caps and Equity-to-Asset data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Smruthi Organics's Equity-to-Asset Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Smruthi Organics's Equity-to-Asset distribution charts can be found below:

* The bar in red indicates where Smruthi Organics's Equity-to-Asset falls into.



Smruthi Organics Equity-to-Asset Calculation

Equity to Asset ratio measures the ratios of the portion of the asset owned by shareholders out of the total asset. It indicates the leverage of the company, and the amount of debt the company uses in its operation.

Equity to Asset ratio is calculated by dividing total stockholders equity by total asset.

Smruthi Organics's Equity to Asset Ratio for the fiscal year that ended in Mar. 2024 is calculated as

Equity to Asset (A: Mar. 2024 )=Total Stockholders Equity/Total Assets
=696.187/1181.907
=0.59

Smruthi Organics's Equity to Asset Ratio for the quarter that ended in Mar. 2024 is calculated as

Equity to Asset (Q: Mar. 2024 )=Total Stockholders Equity/Total Assets
=696.187/1181.907
=0.59

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Smruthi Organics  (BOM:540686) Equity-to-Asset Explanation

Equity to Asset ratio can vary greatly across different industries, as they have different capital structure. A company with smaller Equity to Asset ratio (more leveraged) may have higher ROE % because of the leverage.

For banks, the required minimum Equity to Asset ratio by regulation is 5%. Some stronger banks may have Equity to Asset Ratio of more than 10%.


Smruthi Organics Equity-to-Asset Related Terms

Thank you for viewing the detailed overview of Smruthi Organics's Equity-to-Asset provided by GuruFocus.com. Please click on the following links to see related term pages.


Smruthi Organics (BOM:540686) Business Description

Traded in Other Exchanges
N/A
Address
165-A, Balaji Bhavan, 1st Floor, Railway Lines, Solapur, MH, IND, 413 001
Smruthi Organics Ltd is engaged in the manufacture of bulk drugs and drug intermediates (API Products). The product portfolio includes Amlodipine Besilate, Amlodipine Base, S-Amlodipine Besilate, S-Amlodipine Base, Norfloxacin, Metformin HCI, Diloxanide Furoate, Phthaloyl Amlodipine, Pantoprazole Sodium, Pefloxacin Mesylate Dihydrate, Telmisartan, Losartan Potassium and many more. It has two segments Bulk Drugs and Drugs Intermediates (API) and Formulation. it generates the majority of its revenue from the Bulk Drugs and Drugs Intermediates (API) segment.

Smruthi Organics (BOM:540686) Headlines

No Headlines